Search research articles
Contact Us
Filters
Showing results (41-50 of 191) with videos related to
Page
of 20
Sort By:
JNCI Cancer Spectrum
|
January 13, 2021
Low-Dose Radiation Therapy for COVID-19: Promises and Pitfalls
Bhanu P Venkatesulu, Scott Lester, Cheng-En Hsieh, et al.
Journal for Immunotherapy of Cancer
|
July 6, 2021
Ocular adverse events in PD-1 and PD-L1 inhibitors
LeAnne Young, Shanda Finnigan, Howard Streicher, et al.
Journal of the National Cancer Institute
|
January 20, 2024
Correlation between tumor size change and outcome in a rare cancer immunotherapy basket trial
Megan Othus, Sandip P Patel, Young K Chae, et al.
Iscience
|
August 2, 2020
ACE2 Co-evolutionary Pattern Suggests Targets for Pharmaceutical Intervention in the COVID-19 Pandemic
Maya Braun, Elad Sharon, Irene Unterman, et al.
The Oncologist
|
October 23, 2020
Organ Dysfunction in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors
Susan Spillane, Shrujal Baxi, Aracelis Z Torres, et al.
Frontiers in Plant Science
|
June 26, 2023
Developmental and temporal changes in petunia petal transcriptome reveal scent-repressing plant-specific RING-kinase-WD40 protein
Ekaterina Shor, Oded Skaliter, Elad Sharon, et al.
Cancer Medicine
|
August 28, 2024
Evolving patterns in systemic treatment utilization and survival among older patients with advanced cutaneous melanoma
Yoon Duk Hong, Lindsey Enewold, Elad Sharon, et al.
NAR Genomics and Bioinformatics
|
April 30, 2021
CladeOScope: functional interactions through the prism of clade-wise co-evolution
Tomer Tsaban, Doron Stupp, Dana Sherill-Rofe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 3, 2017
From Famine to Feast: Developing Early-Phase Combination Immunotherapy Trials Wisely
Daphne Day, Arta M Monjazeb, Elad Sharon, et al.
Journal for Immunotherapy of Cancer
|
July 24, 2023
Society for Immunotherapy of Cancer (SITC) checkpoint inhibitor resistance definitions: efforts to harmonize terminology and accelerate immuno-oncology drug development
Harriet M Kluger, Hussein Tawbi, David Feltquate, et al.
Page
of 20
Search research articles
Search
Showing results (41-50 of 191) with videos related to
Sort By:
Page
of 20
JNCI Cancer Spectrum
|
January 13, 2021
Low-Dose Radiation Therapy for COVID-19: Promises and Pitfalls
Bhanu P Venkatesulu, Scott Lester, Cheng-En Hsieh, et al.
Journal for Immunotherapy of Cancer
|
July 6, 2021
Ocular adverse events in PD-1 and PD-L1 inhibitors
LeAnne Young, Shanda Finnigan, Howard Streicher, et al.
Journal of the National Cancer Institute
|
January 20, 2024
Correlation between tumor size change and outcome in a rare cancer immunotherapy basket trial
Megan Othus, Sandip P Patel, Young K Chae, et al.
Iscience
|
August 2, 2020
ACE2 Co-evolutionary Pattern Suggests Targets for Pharmaceutical Intervention in the COVID-19 Pandemic
Maya Braun, Elad Sharon, Irene Unterman, et al.
The Oncologist
|
October 23, 2020
Organ Dysfunction in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors
Susan Spillane, Shrujal Baxi, Aracelis Z Torres, et al.
Frontiers in Plant Science
|
June 26, 2023
Developmental and temporal changes in petunia petal transcriptome reveal scent-repressing plant-specific RING-kinase-WD40 protein
Ekaterina Shor, Oded Skaliter, Elad Sharon, et al.
Cancer Medicine
|
August 28, 2024
Evolving patterns in systemic treatment utilization and survival among older patients with advanced cutaneous melanoma
Yoon Duk Hong, Lindsey Enewold, Elad Sharon, et al.
NAR Genomics and Bioinformatics
|
April 30, 2021
CladeOScope: functional interactions through the prism of clade-wise co-evolution
Tomer Tsaban, Doron Stupp, Dana Sherill-Rofe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 3, 2017
From Famine to Feast: Developing Early-Phase Combination Immunotherapy Trials Wisely
Daphne Day, Arta M Monjazeb, Elad Sharon, et al.
Journal for Immunotherapy of Cancer
|
July 24, 2023
Society for Immunotherapy of Cancer (SITC) checkpoint inhibitor resistance definitions: efforts to harmonize terminology and accelerate immuno-oncology drug development
Harriet M Kluger, Hussein Tawbi, David Feltquate, et al.
Page
of 20